| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,440 |
1,275 |
$55K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
769 |
679 |
$38K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
545 |
533 |
$35K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,262 |
1,125 |
$25K |
| 87428 |
|
222 |
207 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
263 |
234 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
305 |
273 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
111 |
84 |
$10K |
| 99201 |
|
203 |
198 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
102 |
95 |
$6K |
| 0012A |
|
155 |
155 |
$5K |
| 0011A |
|
180 |
176 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
59 |
51 |
$5K |
| 0031A |
|
109 |
109 |
$4K |
| 0013A |
|
23 |
22 |
$800.00 |
| 91301 |
|
45 |
45 |
$0.29 |
| 99072 |
|
36 |
34 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
56 |
54 |
$0.00 |